No association between suicidal, self-injurious thoughts and actions and GLP-1s
The available evidence does not support a causal association between the Glucagon-Like Peptide-1 receptor agonists (GLP-1) – dulaglutide,...
top of page
Browse by category
Search
European Medicines Agency to discuss anaesthesia risk for weight-loss drugs
The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
EMA reviewing data after reports of suicidal thoughts and thoughts of self-harm after taking GLP-1a
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is reviewing data on the risk of suicidal...
Browse by tag
bottom of page